Apitope
Develops drugs for treatments of allergic diseases
Total raised
€12M
€12,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2015-08
latest 2015-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood18
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series B | €12M | Wyvern SEED Fund | View deal → |